Company intelligence / Profile preview

T-Cure Bioscience, Inc.

Sherman Oaks, California, United Statest-cure.com ↗

Ownership: Private
Employees: ~14
Development stage: Phase 1

Overview

T-Cure is a clinical-stage immuno-oncology company developing next-generation autologous TCR-T therapies for solid tumors. Its lead program targeting KK-LC‑1 is in Phase 1 trials, with additional candidates against HERV-E and NY‑ESO‑1 in preclinical or early clinical stages. The company’s therapies are designed to address cancers with significant unmet needs by engineering patient-derived immune cells to target novel tumor antigens. Early results include the initiation of first-in-human studies and licensing/partnerships for further development.[5][6][8]

Therapeutic areas: Oncology
Modalities: Autologous cell therapyTCR-T (T cell receptor-engineered T cells)
Industry: Biotech

Drug pipeline

8 assets

KK-LC-1 TCR-T cells

7 more assets in the full pipeline.

Request access →

Partnerships

National Cancer Institute (NCI) – exclusive worldwide license on KK-LC‐1 program and CRADA collaboration on new targets/platforms [7]Rutgers Cancer Institute – clinical research agreement for first-in-human trial of KK-LC‐1 program [6]Immunotech Biopharm Ltd – license agreement to develop/commercialize HERV-E targeted therapy (“800TCR”) in China [8]Atlas Antibodies AB – collaboration on monoclonal antibody development against CT83/KK-LC‐1 [10]

Beyond the preview

Go deeper on T-Cure Bioscience, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-Cure Bioscience, Inc..

Explore the full profile